Head and neck cancer. 3. Toxicity of 24-hour infusions of methotrexate (NSC-740) and protection by leucovorin (NSC-3590) in patients with epidermoid carcinomas.

Lefkowitz, E

Head and neck cancer. 3. Toxicity of 24-hour infusions of methotrexate (NSC-740) and protection by leucovorin (NSC-3590) in patients with epidermoid carcinomas. [electronic resource] - Cancer chemotherapy reports Sep 1967 - 305-11 p. digital

Publication Type: Clinical Trial; Journal Article

0069-0112


Adult
Aged
Carcinoma, Squamous Cell--drug therapy
Clinical Trials as Topic
Female
Head and Neck Neoplasms--drug therapy
Humans
Leucovorin--therapeutic use
Male
Methotrexate--adverse effects
Middle Aged
Mouth Neoplasms--drug therapy